
Neuralink Expands Brain Implant Trials with 12 Global Patients
Sep 10, 2025 01:57 am UTC| Technology Business Science Health
Elon Musks brain-computer interface company, Neuralink, announced that 12 people worldwide have now received its brain implants. This is up from seven patients reported in June, when the companys partner, Barrow...

Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Sep 08, 2025 04:40 am UTC| Insights & Views Science
Since the early days of human space exploration, the endeavour has been haunted by a very good question: why spend so much on space when there are so many urgent problems here on Earth? Its a valid concern, and one that...

NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
Aug 01, 2025 01:25 am UTC| Politics Science Technology
NASAs acting administrator Sean Duffy met with Roscosmos chief Dmitry Bakanov at the Kennedy Space Center in Florida on Thursday, marking the first face-to-face meeting between the U.S. and Russian space leaders since...

NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Jul 26, 2025 02:17 am UTC| Governance Science Technology
NASA is bracing for a significant workforce reduction, with roughly 20% of its employees expected to leave the agency in the coming weeks. According to a NASA spokesperson, about 3,870 staff members are anticipated to...

Jul 06, 2025 12:10 pm UTC| Insights & Views Science
Astronomers manning an asteroid warning system caught a glimpse of a large, bright object zipping through the solar system late on July 1, 2025. The objects potentially interstellar origins excited scientists across the...

Jul 06, 2025 12:10 pm UTC| Insights & Views Science
This week’s announcement of the loss of a methane-detecting satellite, just days before New Zealand was meant to take over mission control, is a blow to the country’s space research sector. New Zealand invested NZ$29...

FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Jun 28, 2025 03:38 am UTC| Health Governance Science
The U.S. Food and Drug Administration (FDA) has removed the Risk Evaluation and Mitigation Strategies (REMS) requirement for all currently approved CAR-T cell therapies, a move expected to improve patient access to these...